• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉血栓形成;危险因素、临床表现及治疗

Portal vein thrombosis; risk factors, clinical presentation and treatment.

作者信息

Sogaard Kirstine K, Astrup Lone B, Vilstrup Hendrik, Gronbaek Henning

机构信息

Department of Medicine V (Hepatology and Gastroenterology), Aarhus University Hospital, Aarhus C, Denmark.

出版信息

BMC Gastroenterol. 2007 Aug 15;7:34. doi: 10.1186/1471-230X-7-34.

DOI:10.1186/1471-230X-7-34
PMID:17697371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1976099/
Abstract

BACKGROUND

Portal vein thrombosis (PVT) is increasingly frequently being diagnosed, but systematic descriptions of the natural history and clinical handling of the condition are sparse. The aim of this retrospective study was to describe risk factors, clinical presentation, complications and treatment of portal vein thrombosis in a single-centre.

METHODS

Sixty-seven patients were identified in the electronic records from 1992 to 2005. All data were obtained from the patient records.

RESULTS

One or more risk factors (e.g. prothrombotic disorder or abdominal inflammation) were present in 87%. Symptoms were abdominalia, splenomegaly, fever, ascites, haematemesis, and weight loss. Abdominalia and fever occurred more frequently in patients with acute PVT. Frequent complications were splenomegaly, oesophageal- and gastric varices with or without bleeding, portal hypertensive gastropathy and ascites. Varices and bleeding were more frequent in patients with chronic PVT. Patients who received anticoagulant therapy more frequently achieved partial/complete recanalization. Patients with varices who were treated endoscopically in combination with beta-blockade had regression of the varices. The overall mortality was 13% in one year, and was dependent on underlying causes.

CONCLUSION

Most patients had a combination of local and systemic risk factors for PVT. We observed that partial/complete recanalization was more frequent in patients treated with anticoagulation therapy, and that regression of varices was more pronounced in patients who where treated with active endoscopy combined with pharmacological treatment.

摘要

背景

门静脉血栓形成(PVT)的诊断日益常见,但对该疾病自然史和临床处理的系统描述却很匮乏。这项回顾性研究的目的是描述单中心门静脉血栓形成的危险因素、临床表现、并发症及治疗情况。

方法

从1992年至2005年的电子记录中识别出67例患者。所有数据均从患者记录中获取。

结果

87%的患者存在一个或多个危险因素(如血栓前状态或腹部炎症)。症状包括腹痛、脾肿大、发热、腹水、呕血和体重减轻。腹痛和发热在急性PVT患者中更常见。常见并发症有脾肿大、伴或不伴出血的食管和胃静脉曲张、门静脉高压性胃病和腹水。静脉曲张和出血在慢性PVT患者中更常见。接受抗凝治疗的患者更常实现部分/完全再通。接受内镜治疗联合β受体阻滞剂治疗的静脉曲张患者,静脉曲张有所消退。一年总体死亡率为13%,且取决于潜在病因。

结论

大多数患者存在PVT的局部和全身危险因素。我们观察到,接受抗凝治疗的患者更常出现部分/完全再通,而接受积极内镜检查联合药物治疗的患者,静脉曲张消退更为明显。

相似文献

1
Portal vein thrombosis; risk factors, clinical presentation and treatment.门静脉血栓形成;危险因素、临床表现及治疗
BMC Gastroenterol. 2007 Aug 15;7:34. doi: 10.1186/1471-230X-7-34.
2
Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.肝硬化部分脾栓塞术后门静脉血栓形成:抗凝治疗的疗效和长期随访。
J Vasc Interv Radiol. 2013 Dec;24(12):1808-16. doi: 10.1016/j.jvir.2013.08.018. Epub 2013 Oct 4.
3
Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.抗凝治疗肝硬化并门静脉血栓形成患者的疗效和安全性。
Clin Gastroenterol Hepatol. 2012 Jul;10(7):776-83. doi: 10.1016/j.cgh.2012.01.012. Epub 2012 Jan 28.
4
Vascular liver disorders (II): portal vein thrombosis.肝脏血管疾病(二):门静脉血栓形成
Neth J Med. 2009 Feb;67(2):46-53.
5
Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.肝硬化合并门静脉血栓形成患者抗凝治疗的效果:系统评价和荟萃分析。
Gastroenterology. 2017 Aug;153(2):480-487.e1. doi: 10.1053/j.gastro.2017.04.042. Epub 2017 May 4.
6
Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study.非肝硬化相关急性门静脉血栓:一项前瞻性多中心随访研究。
Hepatology. 2010 Jan;51(1):210-8. doi: 10.1002/hep.23259.
7
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.肝硬化门静脉血栓形成抗凝治疗的临床影响和安全性。
Am J Gastroenterol. 2019 Feb;114(2):258-266. doi: 10.1038/s41395-018-0421-0.
8
Portal vein thrombosis in the district general hospital: management and clinical outcomes.区总医院门静脉血栓形成:管理与临床结局。
Eur J Gastroenterol Hepatol. 2009 May;21(5):517-21. doi: 10.1097/MEG.0b013e328318ed6b.
9
Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.肝硬化和非肝硬化肝脏患者急性和慢性门静脉血栓形成的血管内治疗
Acta Radiol. 2016 May;57(5):572-9. doi: 10.1177/0284185115595060. Epub 2015 Aug 7.
10
Portal hypertension-related complications after acute portal vein thrombosis: impact of early anticoagulation.急性门静脉血栓形成后门静脉高压相关并发症:早期抗凝的影响
Clin Gastroenterol Hepatol. 2008 Dec;6(12):1412-7. doi: 10.1016/j.cgh.2008.07.031.

引用本文的文献

1
Endovascular Treatment for Acute Portal Vein Thrombosis.急性门静脉血栓形成的血管内治疗
Interv Radiol (Higashimatsuyama). 2024 Mar 27;10:e20230027. doi: 10.22575/interventionalradiology.2023-0027. eCollection 2025 Mar 28.
2
Thrombotic complications following bariatric surgery: how medical tourism poses challenges to comprehensive care in obesity medicine.肥胖症医学中综合治疗面临的挑战:减重手术后的血栓并发症——医疗旅游如何造成影响。
Clin J Gastroenterol. 2024 Dec;17(6):1019-1025. doi: 10.1007/s12328-024-02047-1. Epub 2024 Oct 12.
3
Classification and Management of Portal Vein Thrombosis in Cirrhotic Patients: A Narrative Review.肝硬化患者门静脉血栓形成的分类与管理:一篇叙述性综述
Cureus. 2024 Jul 31;16(7):e65869. doi: 10.7759/cureus.65869. eCollection 2024 Jul.
4
Fatal pulmonary embolism after surgery for small intestinal necrosis caused by idiopathic portal vein thrombosis: a case report.特发性门静脉血栓形成导致小肠坏死手术后发生致命性肺栓塞:一例报告
Surg Case Rep. 2024 Apr 18;10(1):90. doi: 10.1186/s40792-024-01900-2.
5
Venous Thrombosis in Acute Pancreatitis: What to and Not to Do?急性胰腺炎中的静脉血栓形成:该做什么和不该做什么?
Dig Dis Sci. 2024 May;69(5):1537-1550. doi: 10.1007/s10620-024-08418-5. Epub 2024 Apr 10.
6
Portal Vein Thrombosis: State-of-the-Art Review.门静脉血栓形成:最新综述
J Clin Med. 2024 Mar 6;13(5):1517. doi: 10.3390/jcm13051517.
7
Successful Multimodal Treatment of Pancreatic Cancer With Extensive Superior Mesenteric Vein Thrombosis Utilizing Chemotherapy Combined With Direct Oral Anticoagulant.采用化疗联合直接口服抗凝剂成功多模式治疗伴有广泛肠系膜上静脉血栓形成的胰腺癌
Cureus. 2024 Feb 5;16(2):e53657. doi: 10.7759/cureus.53657. eCollection 2024 Feb.
8
Single-Dose enoxaparin for portomesenteric venous thrombosis prophylaxis after sleeve gastrectomy.单剂量依诺肝素预防袖状胃切除术后门腔静脉血栓形成。
Ann Afr Med. 2024 Jan-Mar;23(1):46-52. doi: 10.4103/aam.aam_133_23.
9
A rare case of esophageal variceal bleeding as a result of portal hypertension due to extra-hepatic portal vein obstruction and its management in a 7-year-old.一名7岁儿童因肝外门静脉阻塞导致门静脉高压引起食管静脉曲张破裂出血的罕见病例及其治疗
Int J Surg Case Rep. 2024 Mar;116:109362. doi: 10.1016/j.ijscr.2024.109362. Epub 2024 Feb 8.
10
A Young Male With Non-cirrhotic Cryptogenic Portal Cavernoma: An Authoritative Case Study.一名患有非肝硬化性隐源性门静脉海绵样变性的年轻男性:一项权威病例研究。
Cureus. 2023 Dec 15;15(12):e50570. doi: 10.7759/cureus.50570. eCollection 2023 Dec.

本文引用的文献

1
Whole blood thrombelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients.
Scand J Clin Lab Invest. 2006;66(4):329-36. doi: 10.1080/00365510600672783.
2
Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies.门静脉血栓形成:患病率、患者特征及终生风险:一项基于23796例连续尸检的人群研究
World J Gastroenterol. 2006 Apr 7;12(13):2115-9. doi: 10.3748/wjg.v12.i13.2115.
3
A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation.急性胃静脉曲张出血内镜治疗的随机试验:氰基丙烯酸正丁酯注射与套扎术对比
Hepatology. 2006 Apr;43(4):690-7. doi: 10.1002/hep.21145.
4
Imaging and radiological interventions of portal vein thrombosis.门静脉血栓形成的影像学与放射介入治疗
Acta Radiol. 2005 Jul;46(4):336-43. doi: 10.1080/02841850510021157.
5
The evolving role of endoscopic treatment for bleeding esophageal varices.内镜治疗在食管静脉曲张出血中不断演变的作用。
World J Surg. 2005 Aug;29(8):966-73. doi: 10.1007/s00268-005-0138-2.
6
Portal vein thrombosis: what is the role of genetics?门静脉血栓形成:遗传学起什么作用?
Eur J Gastroenterol Hepatol. 2005 Jul;17(7):705-7. doi: 10.1097/01.meg.0000170927.60979.1d.
7
Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension.门静脉高压领域不断发展的共识。巴韦诺IV门静脉高压诊断与治疗方法共识研讨会报告
J Hepatol. 2005 Jul;43(1):167-76. doi: 10.1016/j.jhep.2005.05.009.
8
Review article: portal vein thrombosis -- new insights into aetiology and management.综述文章:门静脉血栓形成——病因学与管理的新见解
Aliment Pharmacol Ther. 2005 Jan 1;21(1):1-9. doi: 10.1111/j.1365-2036.2004.02301.x.
9
Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.体外添加血浆代用品后的血栓弹力图全血凝块形成:纤维蛋白原浓缩物对诱导性凝血病的改善作用
Br J Anaesth. 2005 Mar;94(3):324-9. doi: 10.1093/bja/aei052. Epub 2004 Dec 17.
10
Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.肝硬化患者门静脉血栓形成的危险因素及临床表现
J Hepatol. 2004 May;40(5):736-41. doi: 10.1016/j.jhep.2004.01.001.